Vioxx News Articles
Merck
Pulls Arthritis Drug Vioxx from Market
Pharmaceutical giant Merck & Co. is pulling its
arthritis drug Vioxx from the market after a study confirmed earlier concerns
that it raises the risk of heart problems, including heart attacks and
stroke. Vioxx is currently used by 2 million people worldwide and has
been used by more than 84 million people around the world, according to
Merck.
Merck
halts Vioxx sales
USATODAY.com via Yahoo! News - Oct 01 3:33 AM
Pharmaceutical giant Merck & Co. (MRK) is pulling its blockbuster
arthritis drug Vioxx from the market worldwide because data from a clinical
trial found an increased risk of heart attack and stroke.
Arthritis
Drug Vioxx Pulled; Risk of Heart Attacks Is Cited
Los Angeles Times via Yahoo! News - Oct 01 2:30
AM
Merck & Co. voluntarily withdrew its blockbuster arthritis drug Vioxx
from the market Thursday after a new study showed that it nearly doubled
the risk of heart attacks and strokes among people taking it for at least
18 months or longer.
Merck
estimates $2.5B impact from pulling Vioxx plug
Business - USATODAY.com - Fri Oct 1, 6:33 AM ET
With that announcement Thursday, drug giant Merck ended the life of a
pain-relief drug that was part of the most successful product launch in
history when it hit the market in 1999.
Merck
braces for wave of Vioxx lawsuits
The fallout over removing the drug will not be as bad
as the fen-phen case, lawyers say.
Answers
for those who take Vioxx
Business - USATODAY.com - Fri Oct 1, 6:33 AM ET
An estimated 2 million Americans are taking the blockbuster pain reliever
Vioxx, which is being withdrawn from the market because of concerns about
heart attacks and strokes. USA TODAY's Rita Rubin gets answers from the
experts on what led to Merck's decision and what it means for patients:
